European and South Korean authorities are vying for Gilead Sciences' potential COVID-19 treatment, remdesivir, even though the drugmaker has yet to gain regulatory approval in either market and is still ramping up production of the anti-viral drug.
Authorities in Lombardy, the northern Italian region at the centre of one of Europe's worst coronavirus outbreaks, have rebuffed requests to top up health service budgets to cover huge increases in services from homecare operators.
The U.S. Food and Drug Administration on Friday approved Abbvie Inc's oral treatment for managing heavy menstrual bleeding associated with fibroids in premenopausal women.
Thirty-seven countries and the World Health Organization (WHO) appealed on Friday for common ownership of vaccines, medicines and diagnostic tools to tackle the global coronavirus pandemic, taking aim at patent laws they fear could become a barrier to sharing crucial supplies.
Sanofi has temporarily stopped recruiting new COVID-19 patients for its two clinical trials on hydroxychloroquine and will not supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up, it said on Friday.
South Africa has a backlog of more than 96,000 unprocessed specimens awaiting coronavirus tests, the health ministry said on Friday, reflecting what it called a global shortage of test kits.
The United Kingdom's death toll from confirmed cases of COVID-19 has risen by 324 to 38,161, finance minister Rishi Sunak said on Friday.
Deaths from the COVID-19 epidemic in Italy climbed by 87 on Friday, against 70 the day before, the Civil Protection Agency said, while the daily tally of new cases fell to 516 from 593 on Thursday.
Robots that speak more than 53 languages, detect fever and determine if people are wearing face masks properly have been rolled out in Belgium as a first line of control in hospitals and shops.
Spain's Health Ministry said recorded deaths from the coronavirus outbreak reached 27,121 on Friday, increasing by two in the last 24 hours.